MDMA

MDMA and the “Ecstasy Paradigm”

This review (2014) examines the lack of evidence to support the notion that MDMA causes widespread cognitive deficits among its users and critiques a prevalent 'ecstasy paradigm' which exaggerates the negative effects of this substance, sustains publication bias by ignoring methodological shortcomings of their study design, and disregarding its therapeutic potential. Although MDMA poses risks to its users, there is no wide-scale evidence to suggest that its users have been damaged, a matter of fact according to the author, which requires no further empiric investigation but a more critical analysis of the already existing evidence.

Authors

  • Cole, J. C.

Published

Journal of Psychoactive Drugs
meta Study

Abstract

For nearly 30 years, there has been a steady flow of research papers highlighting the dangers of MDMA and the implications for ecstasy users. After such a long time, it would be reasonable to expect that these dangers would be obvious due to the large number of ecstasy users. The available evidence does not indicate that there are millions of ecstasy users experiencing any problems linked to their ecstasy use. The “precautionary principle” suggests that, in the absence of knowing for certain, “experts” should argue that MDMA be avoided. However, this may have been taken too far, as the dire warnings do not seem to be reducing with the lack of epidemiological evidence of clinically relevant problems. The “ecstasy paradigm” is one way of articulating this situation, in that the needs of research funders and publication bias lead to a specific set of subcultural norms around what information is acceptable in the public domain. By digging a little deeper, it is easy to find problems with the evidence base that informs the public debate around MDMA. The key question is whether it is acceptable to maintain this status quo given the therapeutic potential of MDMA.

Available with Blossom Pro

Research Summary of 'MDMA and the “Ecstasy Paradigm”'

Introduction

Cole frames research into controlled drugs as non-neutral, arguing that moral and media narratives shape what questions are asked and how results are reported. The introduction recounts episodes—media misrepresentation of a previous article and the publication then retraction of primate neurotoxicity findings due to a methamphetamine dosing error—to illustrate how the discourse around MDMA/ecstasy is populated by sensational claims and occasional high-profile errors. Against this backdrop Cole introduces the notion of an "ecstasy paradigm": a set of expectations, funding priorities, publication norms, and cultural pressures that bias the literature toward emphasising danger. The central question posed is whether the existing body of evidence is fit for purpose to determine the risks posed by MDMA/ecstasy use, or whether systematic problems mean policy and public debate are based on a distorted evidence base. The paper sets out to examine that evidence and the ways it may be biased or methodologically flawed.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

  • Study Type
    meta
  • Journal
  • Compound
  • APA Citation

    Cole, J. C. (2014). MDMA and the “Ecstasy Paradigm”. Journal of Psychoactive Drugs, 46(1), 44-56. https://doi.org/10.1080/02791072.2014.878148

Cited By (2)

Papers in Blossom that reference this study

Evenings with Molly: Adult Couples’ Use of MDMA for Relationship Enhancement

Colbert, R., Hughes, S. · Culture Medicine and Psychiatry (2022)

Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA

Grob, C. S., Mithoefer, M. C., Brewerton, T. D. · Lancet Psychiatry (2016)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

MDMA and the “Ecstasy Paradigm” — Research Summary & Context | Blossom